Fever -the elevation in body temperature in response to disease -has interested both clinicians and cellular and evolutionary biologists alike. It has been thoroughly established that fever is an adaptive physiological response to infection and that it serves a survival purpose in insects, fish and various cold-blooded animals [1] . For warmblooded species, however, the advantage of fever is not clear and, for humans, the case for any benefit from sustaining an elevated body temperature during an infection is not convincing. Nevertheless, the febrile response remains one of the most conserved -yet, until quite recently, one of the least understood -biological reactions to disease and measuring body temperature is the earliest quantitative and the most frequent clinical assessment in the home and in the hospital.
Fever -the elevation in body temperature in response to disease -has interested both clinicians and cellular and evolutionary biologists alike. It has been thoroughly established that fever is an adaptive physiological response to infection and that it serves a survival purpose in insects, fish and various cold-blooded animals [1] . For warmblooded species, however, the advantage of fever is not clear and, for humans, the case for any benefit from sustaining an elevated body temperature during an infection is not convincing. Nevertheless, the febrile response remains one of the most conserved -yet, until quite recently, one of the least understood -biological reactions to disease and measuring body temperature is the earliest quantitative and the most frequent clinical assessment in the home and in the hospital.
As shown in Figure 1 , the systemic response of fever is the result of a cascade of events that begins with pathogenic infection. In particular, infection with Gram-negative bacteria also results in the release of lipopolysaccharide (LPS), a potent pyrogen, from the bacterial cell wall. In addition to directly triggering endothelial cells of the hypothalamus in the brain, LPS and other bacterial products can stimulate white blood cells to synthesize and release cytokines -soluble proteins that regulate the immune response. Some cytokines are endogenous activators of the hypothalamic thermoregulatory center thereby initiating physiological mechanisms that result in fever.
As the vast majority of infections occur outside the brain, however, cytokines and bacterial products must somehow trigger the hypothalamic neurons inside the brain [2] . The key event at the hypothalamic-endothelial blood brain barrier is the synthesis and release of prostaglandin E 2 (PGE 2 ) into the brain following exposure to pyrogenic cytokines or bacterial LPS. PGE 2 itself cannot stimulate the hypothalamic neurons but instead induces the release of the neurotransmitter cyclic AMP. The resulting effect of pyrogens is to raise body temperature by raising the hypothalamic temperature 'set-point' from the normal level (which in humans is 36.5°C) to a higher level to produce fever. A combination of heat conservation and heat production in the peripheral tissues results in an increased body temperature to match the elevated set-point.
Fever and the study of LPS probably gave birth to the field now known as cytokine biology, or at least the biology of inflammatory cytokines. The link between fever and cytokines was first made with the observation that fever was associated with toxins from bacteria and products of activated white blood cells (reviewed in [3] ). Although many years have passed since that initial observation, relatively little has been elucidated regarding the physiological mechanism responsible for fever. The biology of fever now appears to reach a near-final resolution following the targeted gene disruption of each of the PGE 2 receptors [4] and the identification of the signaling component of the LPS receptor as a member of the interleukin 1 (IL-1)-Toll-like receptor family [5] . As reported by Ushikubi and colleagues [4] , one of the specific PGE 2 receptors termed EP 3 is essential not only for PGE 2 -induced fever but also for fever induced by IL-1β as well as by LPS. This report puts to rest a long, unresolved issue of whether fever-producing mechanisms require PGE 2 or whether there are other mediators of the central nervous system that can raise the hypothalamic set-point.
A persistent, although even mild, elevation in body temperature without an obvious cause is a worrisome concern for the discerning patient and physician. The best 'test' that elevated body temperature is truly fever and an indicator of the presence of disease is to administer an antipyretic agent such as aspirin or acetaminophen, which act by inhibiting cyclooxygenase, an enzyme involved in PGE 2 biosynthesis. Following this treatment, elevated body temperature that is fever quickly falls whereas elevated temperature that is not fever -and is therefore hyperthermia due to excessive metabolic heat production -is unaffected. Thus, the fundamental effect of inhibiting the activity of cyclooxygenase is the decrease in PGE 2 production and the reduction of the fever response. Clinicians rarely have doubted the essential role of inhibiting PGE 2 for reducing fever of any kind including hyperpyrexia (an extremely vigorous form of fever), but researchers using rodent species have repeatedly raised the issue of fever-inducing pathways that do not involve PGE 2 . The report by Ushikubi and colleagues [4] has clarified the field by providing unambiguous results on this issue that are also consistent with years of previous studies on the importance of PGE 2 for fever production [6] .
Ushikubi and co-workers [4] found that mice deficient in EP 3 do not develop fever following intracerebral injection of PGE 2 whereas mice deficient in the other specific types of PGE 2 receptor (EP 1 , EP 2 and EP 4 ) are still able to develop fever. This experiment established that the action of PGE 2 in the brain requires the EP 3 receptor. Intracerebral administration of PGE 2 is not a physiological experiment, however, as it only mimics the fever caused by a central nervous system hemorrhage where plateletderived PGE 2 may play a role. So, what is a physiologically relevant experiment? Most fevers are derived from peripheral infections. These infections stimulate the production of cytokines from various cells but most commonly monocytes and neutrophils. Over 50 years ago, these cytokines were called 'granulocyte pyrogen' or 'endogenous pyrogen' and in many ways initiated cytokine research.
The biology of endogenous pyrogens was dominated by a simple assay, that is, the ability to produce fever in an animal, most commonly a rabbit. The working hypothesis for production of fever was that endogenous pyrogen travelled via the bloodstream to the hypothalamic thermoregulatory system where it triggered neurons to elevate the temperature set-point. Exactly how the set-point was elevated remained unclear until aspirin and other antipyretics were shown to inhibit the synthesis of PGE 2 [7] , endogenous pyrogens where shown to induce PGE 2 production [8] and PGE 2 itself was shown to produce fever [9] . Thus, a logical cascade of events emerged: infection stimulates the production of endogenous pyrogen, which reaches the hypothalamic area where it stimulates the synthesis of PGE 2 ; this is followed by PGE 2 -induced neuronal mechanisms involving cyclic AMP [10] to elevate the temperature set-point, as previously mentioned.
We now know that endogenous pyrogen, as originally proposed by Beeson [11] , is not a single substance. There are several cytokines that produce fever upon intravenous injection and hence each can be termed an endogenous pyrogen. The most potent for humans and rabbits is IL-1β (reviewed in [12] ) but tumor necrosis factor α (TNFα) and IL-6 are also endogenous pyrogens. In fact, there seems to be a hierarchy in the production of these pyrogens in that TNFα induces IL-1β [13] and IL-1β induces IL-6. In mice deficient in IL-6, IL-1β does not produce fever (reviewed in [14] ). It was therefore interesting to determine whether IL-1β would produce fever in the mice deficient in EP 3 . Following intravenous injection of IL-1β, there was no fever in these mice compared with mice deficient in EP 1 , EP 2 and EP 4 and with wild-type mice. It was concluded that IL-1β induced PGE 2 and that, in the absence of EP 3 , there was no febrile response. This conclusion was consistent with the cascade hypothesis mentioned above.
But, as other cytokines are also pyrogenic, it was important to test more than one endogenous pyrogen. To this end, instead of injecting each of the pyrogenic cytokines, R148 Current Biology, Vol 9 No 4
Figure 1
Scheme of the fever response. Most infections trigger a febrile response by stimulating monocytes to synthesize and release several pyrogenic cytokines such as IL-1, TNFα and IL-6. These enter the circulation and reach the endothelial cells of the hypothalamus. From these cells, PGE 2 is released into the brain and binds to EP 3 on cells in the hypothalamic thermoregulatory center. PGE 2 induces the release of cyclic AMP (cAMP), which then acts to raise the thermostatic set-point from normal levels to elevated levels. The elevated set-point results in mechanisms of peripheral heat conservation (vasoconstriction) as well as increased metabolic heat production until the temperature of the blood that bathes the hypothalamus matches the elevated set-point, resulting in fever. Ushikubi and co-workers [4] tested the pyrogenicity of LPS in the EP 3 -deficient mice. They assumed that LPS would induce the synthesis of not only IL-1β but also several other cytokines. Indeed, cells from mice lacking EP 3 produced IL-1β and IL-6 in vitro in response to LPS but did not exhibit fever when injected intravenously with LPS. With the assumption that LPS induces nearly all pyrogenic cytokines -and indeed it does -the implication was that EP 3 is required for mediating the fever not only to IL-1β but also to all LPS-inducible cytokines, including those chemokines (cytokine-related proteins) that have been reported to cause PGE 2 -independent fever (reviewed in [14] ). The failure of EP 3 -deficient mice to develop fever following LPS administration suggests that all cytokines and chemokines of peripheral origin require signaling by PGE 2 for fever induction. To completely resolve the possibility that chemokine-induced fever is PGE 2 independent, it needs to be demonstrated that intracerebral injection of these chemokines does not produce fever in EP 3 -deficient mice.
The story of LPS fever and EP 3 does not stop there. Clearly, the lack of a febrile response to LPS in EP 3 -deficient mice also suggests that any direct action of LPS on the hypothalamus, independent of the induction of cytokines, also requires EP 3 . The requirement of EP 3 for mediating LPS-induced fever brings into account the recent discovery that the signaling chain of the LPS receptor is a member of the Toll-like receptor (TLR) family [5] , which contains proteins related to the primitive Drosophila receptor-like molecule Toll. There are at least five TLRs that are expressed in human cells [15] and function during immune responses [16] . A region of the cytoplasmic domain of the TLRs is homologous to a segment in the IL-1 receptor type I cytoplasmic domain that is required for IL-1 signaling [17] .
As shown in Figure 2 , the biological activity of LPS depends on two non-signaling molecules: the constitutive serum protein lipopolysaccharide-binding protein (LBP) which binds to the lipid chains of LPS; and the membrane protein CD14, to which LBP presents LPS [18] . Although CD14 does not have a cytoplasmic domain for signal transduction, its expression is required for optimal cell responses to LPS. In cells lacking CD14, the addition of LBP does not restore the response to LPS but, in cells expressing CD14, soluble LBP greatly enhances signal transduction by LPS. The existence of a signaling chain for LPS was proposed and, in fact, Lei and Morrison [19] described a cell-surface receptor for LPS with a molecular weight of 80,000. As TLR-2 has a similar molecular weight, it is likely that TLR-2 is this 80,000 kDa LPS receptor. Therefore, LBP binds to LPS and allows for the coupling of TLR-2, resulting in limited signal transduction. Although the binding of LPS to TLR-2 is of very low affinity (500-900 nM) [5] , signaling is greatly enhanced by the presence of CD14 at the membrane. One can now envisage the optimal LPS signaling complex to be TLR-2-LPS-CD14. Of related interest, the LPS-resistant mouse strain C3H/HeJ has a mutation in TLR-4 [20] , suggesting that other TLRs may be involved in LPS signaling.
The biological responses to LPS are often indistinguishable from those to IL-1 or TNFα. In terms of fever research, a small amount (3 ng/kg) of LPS injected intravenously into rabbits produced a monophasic fever nearly identical to that following an intravenous injection of 30 ng/kg of TNFα or IL-1β [21] . It could have easily been predicted that cell signaling induced by LPS and IL-1 or TNFα proceeded via very similar pathways. With the present finding of TLR-2 as a signaling component for LPS, the basis for the similarities to IL-1 signaling can be understood.
What is unresolved? The characteristic fever response to intravenously injected IL-1β, TNFα, IL-6 or LPS is rapid; in rabbits, the peak elevation of core temperature occurs 50-60 minutes after injection and in mice at 20-25 minutes. Thus, the initiating event in the synthesis of PGE 2 for fever production must occur even earlier and probably results in the rapid release of arachidonic acid, the rate-limiting step in the synthesis of PGE 2 . Therefore, to fit into the current understanding of the scheme, IL-1β, IL-6, TNFα and LPS would each have to bring about the rapid release of arachidonic acid from lipid precursors in the cell membrane (see Figure 2) . In fact, an increase in PGE 2 levels in the hypothalamic tissues surrounding the thermoregulatory center has been found following IL-1β and IL-6 treatment [22] .
The signaling mechanism of IL-1β, IL-6, TNFα and LPS that results in the release of arachidonic acid has not been clearly demonstrated, however. In some cells, IL-1β will induce the rapid release of phosphatidylcholine and diacylglycerol from phospholipid precursors [23] . As diacylglycerol contains arachidonic acid as one of its fatty acid components, it could be a possible source of arachidonic acid. Various neuronal stimuli have been described to activate phospholipase A 2 and this may also lead to the generation of arachidonic acid. The main source of substrate for rapid PGE 2 synthesis in response to cytokines and LPS is the key puzzle in this important field that remains to be solved. We shall look forward to finding the solution.
